{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:37:04Z","timestamp":1792975024847,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["OTKA FK147194"],"award-info":[{"award-number":["OTKA FK147194"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Hungarian Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003827","name":"National Research Development and Innovation Office","doi-asserted-by":"publisher","award":["RRF-2.3.1-21-2022-00015"],"award-info":[{"award-number":["RRF-2.3.1-21-2022-00015"]}],"id":[{"id":"10.13039\/501100003827","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Analysis"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jpha.2024.101065","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:42:53Z","timestamp":1722667373000},"page":"101065","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["A gene set enrichment analysis for cancer hallmarks"],"prefix":"10.1016","volume":"15","author":[{"given":"Ot\u00edlia","family":"Menyhart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6203-9744","authenticated-orcid":false,"given":"William Jayasekara","family":"Kothalawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5772-3766","authenticated-orcid":false,"given":"Bal\u00e1zs","family":"Gy\u0151rffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpha.2024.101065_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jpha.2024.101065_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2024.101065_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2024.101065_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jpha.2024.101065_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00099","article-title":"Identification of cancer hallmarks based on the gene co-expression networks of seven cancers","volume":"10","author":"Yu","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.jpha.2024.101065_bib6","article-title":"Molecular principles of metastasis: A hallmark of cancer revisited","volume":"5","author":"Fares","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2024.101065_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.768861","article-title":"The crosstalk between signaling pathways and cancer metabolism in colorectal cancer","volume":"12","author":"Hon","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101065_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1786","article-title":"The RNA interactome in the hallmarks of cancer","volume":"14","author":"Gabryelska","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"key":"10.1016\/j.jpha.2024.101065_bib9","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s13402-023-00806-9","article-title":"Crosstalk between long noncoding RNA and microRNA in cancer","volume":"46","author":"Bhattacharjee","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"key":"10.1016\/j.jpha.2024.101065_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jpha.2024.101065_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s12859-021-04105-8","article-title":"Establishing a consensus for the hallmarks of cancer based on gene ontology and pathway annotations","volume":"22","author":"Chen","year":"2021","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jpha.2024.101065_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: Kyoto Encyclopedia of Genes and Genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101065_bib13","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrg2363","article-title":"Use and misuse of the gene ontology annotations","volume":"9","author":"Rhee","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jpha.2024.101065_bib14","first-page":"300","article-title":"Guidelines for the selection of functional assays to evaluate the hallmarks of cancer","volume":"1866","author":"Menyh\u00e1rt","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.jpha.2024.101065_bib15","article-title":"CHG: A systematically integrated database of cancer hallmark genes","volume":"11","author":"Zhang","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.jpha.2024.101065_bib16","first-page":"439","article-title":"A multilevel pan-cancer map links gene mutations to cancer hallmarks, Chin","volume":"34","author":"Knijnenburg","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.jpha.2024.101065_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/database\/baaa045","article-title":"Curation of cancer hallmark-based genes and pathways for in silico characterization of chemical carcinogenesis","volume":"2020","author":"Liang","year":"2020","journal-title":"Database (Oxford)"},{"key":"10.1016\/j.jpha.2024.101065_bib18","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1111\/jcmm.15174","article-title":"Identification of cancer hallmark-associated gene and lncRNA cooperative regulation pairs and dictate lncRNA roles in oral squamous cell carcinoma","volume":"24","author":"Lin","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jpha.2024.101065_bib19","doi-asserted-by":"crossref","first-page":"D416","DOI":"10.1093\/nar\/gkz871","article-title":"CancerGeneNet: Linking driver genes to cancer hallmarks","volume":"48","author":"Iannuccelli","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101065_bib20","doi-asserted-by":"crossref","first-page":"D941","DOI":"10.1093\/nar\/gky1015","article-title":"COSMIC: The Catalogue Of Somatic Mutations In Cancer","volume":"47","author":"Tate","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101065_bib21","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1101\/gr.133991.111","article-title":"A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers","volume":"22","author":"Plaisier","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.jpha.2024.101065_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cels.2016.06.006","article-title":"Causal mechanistic regulatory network for glioblastoma deciphered using systems genetics network analysis","volume":"3","author":"Plaisier","year":"2016","journal-title":"Cell Syst."},{"key":"10.1016\/j.jpha.2024.101065_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jpha.2024.101065_bib24","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41568-018-0060-1","article-title":"The COSMIC Cancer Gene Census: Describing genetic dysfunction across all human cancers","volume":"18","author":"Sondka","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2024.101065_bib25","doi-asserted-by":"crossref","first-page":"D833","DOI":"10.1093\/nar\/gkw943","article-title":"DisGeNET: A comprehensive platform integrating information on human disease-associated genes and variants","volume":"45","author":"Pi\u00f1ero","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101065_bib26","doi-asserted-by":"crossref","first-page":"D674","DOI":"10.1093\/nar\/gkn653","article-title":"PID: The pathway interaction database","volume":"37","author":"Schaefer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jpha.2024.101065_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: Tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jpha.2024.101065_bib28","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1093\/carcin\/bgv039","article-title":"Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead","volume":"36","author":"Goodson 3rd","year":"2015","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jpha.2024.101065_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btac757","article-title":"GSEApy: A comprehensive package for performing gene set enrichment analysis in Python","volume":"39","author":"Fang","year":"2023","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jpha.2024.101065_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84787-5","article-title":"Pancancer survival analysis of cancer hallmark genes","volume":"11","author":"Nagy","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpha.2024.101065_bib31","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/bph.16257","article-title":"Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer","volume":"181","author":"Gy\u0151rffy","year":"2024","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jpha.2024.101065_bib32","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jpha.2024.101065_bib33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst."},{"key":"10.1016\/j.jpha.2024.101065_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.01203","article-title":"The impact of pathway database choice on statistical enrichment analysis and predictive modeling","volume":"10","author":"Mubeen","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.jpha.2024.101065_bib35","article-title":"Identifying significantly impacted pathways: A comprehensive review and assessment","volume":"20","author":"Nguyen","year":"2019","journal-title":"Genome Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"de Bruin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101065_bib37","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1245\/s10434-020-08400-1","article-title":"Wait-and-see treatment strategy could be considered for lung adenocarcinoma with special pleural dissemination lesions, and low genomic instability correlates with better survival","volume":"27","author":"Chen","year":"2020","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jpha.2024.101065_bib38","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/0929867324666161118125103","article-title":"The role of the antiangiogenetic ramucirumab in the treatment of advanced non small cell lung cancer","volume":"24","author":"Maione","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.jpha.2024.101065_bib39","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrm2858","article-title":"Genomic instability \u2014 An evolving hallmark of cancer","volume":"11","author":"Negrini","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib40","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.semcancer.2015.03.005","article-title":"Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition","volume":"35","author":"Ferguson","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006881","article-title":"Estimating the number of genetic mutations (hits) required for carcinogenesis based on the distribution of somatic mutations","volume":"15","author":"Anandakrishnan","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib42","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.jpha.2024.101065_bib43","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1126\/science.aag0299","article-title":"Mutational signatures associated with tobacco smoking in human cancer","volume":"354","author":"Alexandrov","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jpha.2024.101065_bib44","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MPA.0000000000001550","article-title":"The diverse involvement of cigarette smoking in pancreatic cancer development and prognosis","volume":"49","author":"Weissman","year":"2020","journal-title":"Pancreas"},{"key":"10.1016\/j.jpha.2024.101065_bib45","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12072-013-9494-4","article-title":"Mechanisms of alcohol-induced hepatocellular carcinoma","volume":"8","author":"Sidharthan","year":"2014","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.jpha.2024.101065_bib46","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jpha.2024.101065_bib47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2024.101065_bib48","first-page":"735","article-title":"Microsatellite instability in colorectal cancer: Overview of its clinical significance and novel perspectives","volume":"16","author":"Battaglin","year":"2018","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.jpha.2024.101065_bib49","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1007\/s00018-018-2906-9","article-title":"Microsatellite instability in gastric cancer: Molecular bases, clinical perspectives, and new treatment approaches","volume":"75","author":"Ratti","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.jpha.2024.101065_bib50","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ncb2641","article-title":"p53 mutations in cancer","volume":"15","author":"Muller","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.phrs.2018.08.013","article-title":"Targeting oncogenic Raf protein-serine\/threonine kinases in human cancers","volume":"135","author":"Roskoski","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jpha.2024.101065_bib52","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2024.101065_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cell.2017.06.009","article-title":"RAS proteins and their regulators in human disease","volume":"170","author":"Simanshu","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.jpha.2024.101065_bib54","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jpha.2024.101065_bib55","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/jcb.22214","article-title":"Role of hypoxia in the hallmarks of human cancer","volume":"107","author":"Ruan","year":"2009","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.jpha.2024.101065_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04029-2","article-title":"Identification of hub genes and potential molecular mechanisms related to radiotherapy sensitivity in rectal cancer based on multiple datasets","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jpha.2024.101065_bib57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2015.216","article-title":"MYC in pancreatic cancer: Novel mechanistic insights and their translation into therapeutic strategies","volume":"35","author":"Hessmann","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jpha.2024.101065_bib58","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","article-title":"Concepts to target MYC in pancreatic cancer","volume":"15","author":"Wirth","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jpha.2024.101065_bib59","article-title":"Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis","volume":"9","author":"Li","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jpha.2024.101065_bib60","article-title":"The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jpha.2024.101065_bib61","doi-asserted-by":"crossref","DOI":"10.1590\/1678-4685-gmb-2020-0054","article-title":"A comparison of mRNA and circRNA expression between squamous cell carcinoma and adenocarcinoma of the lungs","volume":"43","author":"Yu","year":"2020","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.jpha.2024.101065_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.21037\/jtd-21-1921","article-title":"The co-mutation of EGFR and tumor-related genes leads to a worse prognosis and a higher level of tumor mutational burden in Chinese non-small cell lung cancer patients","volume":"14","author":"Zhang","year":"2022","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.jpha.2024.101065_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2020.103119","article-title":"Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma","volume":"156","author":"Lamberti","year":"2020","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jpha.2024.101065_bib64","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.molmed.2019.04.012","article-title":"Abandoning the notion of non-small cell lung cancer","volume":"25","author":"Relli","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jpha.2024.101065_bib65","doi-asserted-by":"crossref","first-page":"35528","DOI":"10.18632\/oncotarget.26217","article-title":"Distinct lung cancer subtypes associate to distinct drivers of tumor progression","volume":"9","author":"Relli","year":"2018","journal-title":"Oncotarget"}],"container-title":["Journal of Pharmaceutical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517792400162X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209517792400162X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T07:19:05Z","timestamp":1750317545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209517792400162X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S209517792400162X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101065","relation":{},"ISSN":["2095-1779"],"issn-type":[{"value":"2095-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A gene set enrichment analysis for cancer hallmarks","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpha.2024.101065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Xi\u2019an Jiaotong University.","name":"copyright","label":"Copyright"}],"article-number":"101065"}}